Correlation between CD4^+CD25^+Treg Cells and CCR4 in Nasopharyngeal Carcinoma
OBJECTIVE CD4^+CD25^+ T regulatory (Treg) cells are a population of T cells which suppress an overactive immune system. CCR4 is a chemokine receptor involved in the recruitment of lymphocytes. Nasopharyngeal carcinoma (NPC) is resistant to immunosurveillance, owing to the increased number of tumor-i...
Saved in:
Published in | Cancer biology & medicine Vol. 8; no. 2; pp. 106 - 113 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Heidelberg
Tianjin Medical University Cancer Institute and Hospital
01.06.2011
China Anti-Cancer Association |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | OBJECTIVE CD4^+CD25^+ T regulatory (Treg) cells are a population of T cells which suppress an overactive immune system. CCR4 is a chemokine receptor involved in the recruitment of lymphocytes. Nasopharyngeal carcinoma (NPC) is resistant to immunosurveillance, owing to the increased number of tumor-infiltrating Treg cells which are recruited to the tumor bv CCR4. |
---|---|
Bibliography: | Yan-xin REN Jun SUI Xin SONG Gee WAN WONG Jing MA Hong YAO Marie Chia-mi LIN Xiao-jiang LI1 Immunotherapy Center, The Third Affiliated Hospital, Kunming Medical College, Kunming 650118, Yunnan Province, China. 2 Head and Neck Surgery, The Third Affiliated Hospital, Kunming Medical College, Kunming 650118, Yunnan Province, China. 3 Institute of Molecular Biology, Department of Chemistry, Open Laboratory of Chemical Biology, The University of Hong Kong, Hong Kong, China. OBJECTIVE CD4^+CD25^+ T regulatory (Treg) cells are a population of T cells which suppress an overactive immune system. CCR4 is a chemokine receptor involved in the recruitment of lymphocytes. Nasopharyngeal carcinoma (NPC) is resistant to immunosurveillance, owing to the increased number of tumor-infiltrating Treg cells which are recruited to the tumor bv CCR4. nasopharyngeal carcinoma, CD4^+CD25^+ Treg cells,CCR4, flow cytometry, tumor-infiltrating lymphocytes. 12-1404/R |
ISSN: | 1674-5361 2095-3941 1868-324X |
DOI: | 10.1007/s11805-011-0567-7 |